Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
6.90
-0.07 (-1.00%)
Apr 25, 2025, 12:44 PM EDT - Market open
Owens & Minor Revenue
In the year 2024, Owens & Minor had annual revenue of $10.70B with 3.55% growth. Owens & Minor had revenue of $2.70B in the quarter ending December 31, 2024, with 1.50% growth.
Revenue (ttm)
$10.70B
Revenue Growth
+3.55%
P/S Ratio
0.05
Revenue / Employee
$461,245
Employees
23,200
Market Cap
533.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.70B | 366.92M | 3.55% |
| Dec 31, 2023 | 10.33B | 378.49M | 3.80% |
| Dec 31, 2022 | 9.96B | 170.16M | 1.74% |
| Dec 31, 2021 | 9.79B | 1.31B | 15.39% |
| Dec 31, 2020 | 8.48B | -730.76M | -7.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
OMI News
- 7 days ago - Owens & Minor: A Painful Transformation - Seeking Alpha
- 15 days ago - Owens & Minor Announces Major Innovations to Products & Healthcare Services Network - Business Wire
- 22 days ago - Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering - Business Wire
- 4 weeks ago - Owens & Minor Announces Launch of Senior Secured Notes Offering - Business Wire
- 2 months ago - Owens & Minor, Inc. (OMI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares - Benzinga
- 2 months ago - Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment - Business Wire
- 2 months ago - Owens & Minor, Inc. (OMI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire